SFI
FUSN

Susquehanna Fundamental Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,168
Closed -$270K – 1812
2021
Q1 		$270K Sell
25,168
-12,677
-33% -$148K ﹤0.01% 1322
2020
Q4 		$445K Sell
37,845
-1,894
-5% -$23.8K 0.01% 1149
2020
Q3 		$478K Buy
+39,739
New +$543K 0.01% 891

Other funds holding FUSN

JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Susquehanna Fundamental Investments's FUSN Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2021, closing a stake of 25,168 shares — an estimated $270K sold.

Susquehanna Fundamental Investments first reported a position in FUSN in Q3 2020 and held it in 3 quarters. The position peaked at $478K in Q3 2020. 39 funds tracked by Wall St. Rank hold FUSN as of Q2 2021.

  • Susquehanna Fundamental Investments reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 25,168 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2021, an estimated $270K.
  • Susquehanna Fundamental Investments first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2020 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Fusion Pharmaceuticals Inc. Common Shares position peaked at $478K in Q3 2020.
  • 39 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.